References
- Singletary K. Red pepper: overview of potential health benefits. Nutr Today. 2011;46(1):33-47. https://doi.org/10.1097/NT.0b013e3182076ff2
- Pawar SS, Bharude NV, Sonone SS, Deshmukh RS, Raut AK, Umarkar AR. Chillies as food, spice and medicine: a perspective. Int J Pharm Biol Sci. 2011;1(3):311-8.
- Silva C, Rio ME, Cruz F. Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia. Eur Urol. 2000;38(4):444-52. https://doi.org/10.1159/000020322
- McCarty MF, DiNicolantonio JJ, O'Keefe JH. Capsaicin may have important potential for promoting vascular and metabolic health. Open Heart. 2015;2(1):e000262. https://doi.org/10.1136/openhrt-2015-000262
- Ito K, Nakazato T, Yamato K, Miyakawa Y, Yamada T, Hozumi N, et al. Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res. 2004;64(3):1071-8. https://doi.org/10.1158/0008-5472.CAN-03-1670
- Hail N Jr, Lotan R. Examining the role of mitochondrial respiration in vanilloid-induced apoptosis. J Natl Cancer Inst. 2002; 94(17):1281-92. https://doi.org/10.1093/jnci/94.17.1281
- Stander S, Luger T, Metze D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol. 2001;44(3):471-8. https://doi.org/10.1067/mjd.2001.110059
- Jung C, Jung JH, Lee MS. A clinical study of immune pharmacopuncturology. Yeongi: Kyungrak Medical Publishing Co.; 2011. p. 127-33.
- Korean Acupuncture and Moxibustion Society. Acupuncture medicine. Seoul: Hanmi Medical Publishing Co.; 2020. 932 p.
- Kim HJ, Gwan R, Han JW, Jung C. Anti-oxidant anti-inflammatory effects of V Yakchim. J Korea Immuno-Yakchim Soc. 2013; 2(1):1-8.
- Jung C. In vivo micronucleus test of V-YAKCHIM in ICR mice. J Korea Immuno-Yakchim Soc. 2013;2(2):5-10.
- Cho S, Jung C, Kim K, Ko S, Jung H, Park J. A case study of acute appendicitis improved by pharmacopuncture treatment. J Intern Korean Med. 2019;40(2):208-19. https://doi.org/10.22246/jikm.2019.40.2.208
- Chung YJ, Lee HJ, Lee YK, Lee JH, Gong HM, Jun SA, et al. Case report of hypoesthesia of lower limb with additional CP pharmacopuncture. J Physiol Pathol Korean Med. 2019;33(2):158-62. https://doi.org/10.15188/kjopp.2019.04.33.2.158
- Jeong JH, Hwang JH. Korean medicine treatment including capsaicin-containing (CP) pharmacopuncture for acute low back and hip pain: a case report of 3 patients. Korean J Acupunct. 2020;37(3):191-7. https://doi.org/10.14406/acu.2020.020
- Hwang JH, Ku J, Jung C. Evaluation of the single-dose toxicity of capsaicin pharmacopuncture in rats. J Acupunct Res. 2020; 37(3):167-72. https://doi.org/10.13045/jar.2020.00185
- Hwang JH, Ku J, Jung C. Bacterial reverse mutation test of CP pharmacopunture. J Korean Med. 2020;41(3):55-68. https://doi.org/10.13048/jkm.20025
- Korea Food and Drug Administration (KFDA). Good Laboratory Practice (GLP). [Internet]. Cheongju: KFDA; c2017 [cited 2017 May 1]. Available from: http://www.law.go.kr/admRulInfoP.do?admRulSeq=2100000086689.
- Korea Food and Drug Administration (KFDA). Partial Amendment Official Announcement about Toxicity Test for Drug [Internet]. Cheongju: KFDA; 2015 Nov 11 [updated 2015 Nov 11; cited 2015 Nov 11]. Available from: https://www.law.go.kr/LSW/admRulLsInfoP.do?chrClsCd=010202&admRulSeq=2100000032147.
- Organisation for Economic Co-operation and Development (OECD). ENV/MC/CHEM(98)17: OECD series on principles of good laboratory practice and compliance monitoring number 1. Paris: OECD; 1998. 41 p
- Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol. 2001;21(1):15-23. https://doi.org/10.1002/jat.727
- Teschke R, Wolff A, Frenzel C, Schulze J. Review article: herbal hepatotoxicity--an update on traditional Chinese medicine preparations. Aliment Pharmacol Ther. 2014;40(1):32-50. https://doi.org/10.1111/apt.12798
- Kim EJ, Chen Y, Huang JQ, Li KM, Razmovski-Naumovski V, Poon J, et al. Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines. J Ethnopharmacol. 2013;146(1):40-61. https://doi.org/10.1016/j.jep.2012.12.027
- Lee MY, Seo CS, Kim JY, Shin HK. Genotoxicity evaluation of Guibi-Tang extract using an in vitro bacterial reverse mutation assay, chromosome aberration assay, and in vivo micronucleus test. BMC Complement Altern Med. 2014;14:215. https://doi.org/10.1186/1472-6882-14-215
- Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, et al. Report from the in vitro micronucleus assay working group. Mutat Res. 2003;540(2):153-63. https://doi.org/10.1016/j.mrgentox.2003.07.005